Navigation Links
differ in Biological Technology

KV Pharmaceutical Announces Stockholder Action to Amend By-Laws is Invalid

...cautionary statements identifying important economic, political and technological factors, which among others, could cause actual results or events to differ materially from those set forth or implied by the forward-looking statements and related assumptions. Such factors include (but are not limited...

Schering-Plough Shareholders Approve Merger With Merck

...ough does not assume the obligation to update any forward-looking statement. A number of risks and uncertainties could cause actual results to differ materially from forward-looking statements, including, among other uncertainties, market viability of the company's and Merck's marketed products and ...

SCOLR Pharma, Inc. Reports Second Quarter 2009 Financial Results

... may occur in the future. A number of factors could cause actual results to differ from those indicated in the forward-looking statements, including our abili...uarantees of future performance and that actual results or developments may differ materially from those set forth in the forward-looking statements. We und...

Novavax Reports Second Quarter 2009 Financial Results

...ward-looking statements are subject to numerous assumptions, risks and uncertainties, which change over time. Factors that may cause actual results to differ materially from the results discussed in the forward-looking statements or historical experience include risks and uncertainties, including the Compan...

Kensey Nash Announces Agreement to Acquire Rights to OsseoFit Product

...ng such statements. The Company cautions that a number of risks, uncertainties and other important factors could cause the Company's actual results to differ materially from those in the forward-looking statements including, without limitation, current economic conditions, foreign currency fluctuations, ris...

Catalyst Pharmaceutical Partners Reports Second Quarter 2009 Financial Results

...ements. Forward-looking statements involve known and unknown risks and uncertainties which may cause the Company's actual results in future periods to differ materially from forecasted results. A number of factors, including our ability to successfully complete the clinical trials required for us to file a ...

NeurogesX Reports Second Quarter 2009 Results

... fund the Company's operations for at least the next 12 months. Such statements are based on management's current expectations, but actual results may differ materially due to various risks and uncertainties, including, but not limited to; positive results in clinical trials may not be sufficient to obtain ...

AOBO Announces New Product Launch

...statements involve risks and uncertainties that may cause actual results to differ materially from those set forth in these statements. The economic, competit...for the year ended December 31, 2008, may cause actual results or events to differ materially from those described in the forward looking statements in this p...

American Oriental Bioengineering Reports Second Quarter 2009 Financial Results

...statements involve risks and uncertainties that may cause actual results to differ materially from those set forth in these statements. The economic, competit...for the year ended December 31, 2008, may cause actual results or events to differ materially from those described in the forward looking statements in this p...

Onyx Pharmaceuticals Announces Pricing of Concurrent Offerings of Four Million Shares of Common Stock and $200 Million Principal Amount of Convertible Senior Notes

...o completion and timing of any public offering. These statements are subject to risks and uncertainties that could cause actual results and events to differ materially from those anticipated, including risks and uncertainties related to the financial markets. Reference should be made to Onyx's Annual Repo...

AutoImmune Inc. Reports 2009 Second Quarter Financial Results

... These forward-looking statements are not guarantees of future performance and are subject to risks and uncertainties that may cause actual results to differ materially from those in the forward-looking statements as a result of any number of factors. These factors include, but are not limited to the uncert...

ThermoGenesis Announces Expanded Collaboration With Celling Technologies

...tements involve risks and uncertainties that could cause actual outcomes to differ materially from those contemplated by the forward-looking statements. Sever...lete description of these and other risks that could cause actual events to differ from the outcomes predicted by our forward-looking statements is set forth ...

Synthetech Reports First Quarter Fiscal 2010 Results

... are inherently uncertain and actual results could differ materially from such expectations, plans or projec...d uncertainties that could cause actual results to differ significantly from management's expectations inclu... of the factors that could cause actual results to differ significantly from management's expectations. Add...

Microbix Sales Grow 22% For Nine Months

... Toronto. This press release contains forward-looking statements, which are subject to risks and uncertainties that could cause actual results to differ materially from those set forth in the forward-looking statements including the risks associated with failure to get authorization to release Kinlytic...

GenVec Reports Second Quarter 2009 Financial Results

...ard-looking statements are subject to numerous assumptions, risks and uncertainties, which change over time. Factors that may cause actual results to differ materially from the results discussed in the forward-looking statements or historical experience include risks and uncertainties, including the failur...

ThermoGenesis Provides Update on Fiscal 2009 Results

...tements involve risks and uncertainties that could cause actual outcomes to differ materially from those contemplated by the forward-looking statements. Sever...lete description of these and other risks that could cause actual events to differ from the outcomes predicted by our forward-looking statements is set forth ...

InterMune Reports Second Quarter 2009 Financial Results and Business Highlights

...s or information. InterMune's actual results could differ materially from those described in InterMune's for...ts of the InterMune CAPACITY trials of pirfenidone differ in some respects from those of the Shionogi & ...ted by Shionogi concerning their Phase 3 trial may differ from those published or presented in a peer-review...

SEQUENOM Reports Second Quarter 2009 Financial Results and Highlights

...ate Securities Litigation Reform Act of 1995. These forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially, including the risks and uncertainties associated with the Company's ability to develop and commercialize new technologies and products, pa...

Telik Announces Second Quarter 2009 Financial Results

...ectations. There are important factors that could cause Telik's results to differ materially from those indicated by these forward-looking statements, includ...s. Detailed information regarding factors that may cause actual results to differ materially from the results expressed or implied by statements in this pres...

China Sky One Medical, Inc. Appoints New Independent Director

...volve risks and uncertainties and may include financial projections or information regarding the change of independent directors. Actual results could differ materially from the expectations reflected in such forward-looking statements as a result of a variety of factors, including the risks associated with...

Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2009

... to certain operating risks that may cause any results expressed or implied by the forward-looking statements in this Quarterly Report on Form 10-Q to differ materially from our actual results. These operating risks include: our ability to attract and retain qualified personnel; our ability to successfully ...

Repligen Reports First Quarter Fiscal Year 2010 Financial Results

...tute forward-looking statements. Such forward-looking statements are subject to a number of risks and uncertainties that could cause actual results to differ materially from those anticipated, including, without limitation, risks associated with: the success of current and future collaborative relationships...

NeurogesX Announces New PDUFA Date for Qutenza(TM) New Drug Application

...ding the timing with respect to entry into such a partnership. Such statements are based on management's current expectations, but actual results may differ materially due to various risks and uncertainties, including, but not limited to; positive results in clinical trials may not be sufficient to obtain ...

Keryx Biopharmaceuticals, Inc. Announces Second Quarter 2009 Financial Results

...forward-looking statements contained in the Private Securities Litigation Reform Act of 1995. Among the factors that could cause our actual results to differ materially are the following: There can be no assurance that the Company will complete cost-effective clinical trials or meet the projected developmen...

Exciton Technologies receives FDA approval to market exSALT(TM)

...y's ability to protect its intellectual property, involve known and unknown risks and uncertainties, which could cause the Company's actual results to differ materially from those in the forward looking statements. Such risks and uncertainties include, among others, the availability of funds and resources t...

PDI Reports 2009 Second Quarter Financial Results

... to statements regarding projections of future revenues, actual results may differ materially from those set forth in this release based on the loss, early te... prospects for PDI's future growth and/or profitability, actual results may differ materially based on adverse market conditions, PDI's inability to successfu...

Amicus Therapeutics Announces Second Quarter 2009 Financial Results

... and results of preclinical studies and clinical trials, actual results may differ materially from those set forth in this release due to the risks and uncert...ny's cash position and expected use of cash during 2009, actual results may differ based on market factors, the company's ability to execute its operational a...

Cadence Pharmaceuticals Reports Second Quarter 2009 Financial Results

...ward-looking statements such as these should not be regarded as a representation by Cadence that any of its plans will be achieved. Actual results may differ materially from those set forth in this press release due to the risks and uncertainties inherent in the company's business, including, without limita...

Pharmasset to Present at Canaccord Adams Conference

...ll not be successfully developed and commercialized. For a discussion of these risks and uncertainties, any of which could cause our actual results to differ from those contained in the forward-looking statements, see the section of our Annual Report on Form 10-K for the fiscal year ended September 30, 2008...

ADVENTRX Pharmaceuticals Announces Financing

...ward-looking statements that involve risks and assumptions that, if they materialize or do not prove to be accurate, could cause ADVENTRX's results to differ materially from historical results or those expressed or implied by such forward-looking statements. These risks and uncertainties include, but are no...

GeoVax Labs, Inc. Provides Clinical Studies Update

...expectations and assumptions on the date of this press release and are subject to numerous risks and uncertainties which could cause actual results to differ materially from those described in the forward-looking statements. Risks and uncertainties include, but are not limited to, whether: GeoVax can develo...

Advanced Life Sciences to Host 2009 Second Quarter Financial Results Conference Call and Webcast

...Litigation Reform Act of 1995. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. These risks and uncertainties include, among others, those relating to technology ...

ImmunoVaccine Technologies Partners With Scancell to Advance DNA Vaccine Delivery

... the date the statements are made. However, they should not be regarded as a representation that any of the plans will be achieved. Actual results may differ materially from those set forth in this press release due to risks affecting the Company, including access to capital, the successful completion of cl...

Pharmacyclics, Inc. Rights Offering Oversubscribed

...ld", "project", "plan", "predict", "intend" and similar expressions are intended to identify such forward-looking statements. Our actual results could differ materially from those projected in the forward-looking statements. Additionally, you should not consider past results to be an indication of our futur...

Optimer Pharmaceuticals Reports Second Quarter 2009 Financial Results

...clusion of forward-looking statements should not be regarded as a representation by Optimer that any of its plans will be achieved. Actual results may differ materially from those set forth in this release due to the risks and uncertainties inherent in Optimer's business including, without limitation, risks...

NxStage Reports Second Quarter 2009 Financial Results

...ve risks, uncertainties and contingencies, many of which are beyond NxStage's control, which may cause actual results, performance, or achievements to differ materially from anticipated results, performance or achievements, including market acceptance and demand for NxStage's products, growth in home and/or...

The Foundation for National Institutes of Health Announces Unprecedented Product Donation by sanofi-aventis in the U.S.

...inties, many of which are difficult to predict and generally beyond the control of sanofi-aventis, that could cause actual results and developments to differ materially from those expressed in, or implied or projected by, the forward-looking information and statements. These risks and uncertainties include ...

Poniard Pharmaceuticals Reports Second Quarter 2009 Financial Results and Provides a Corporate Update

...ans, the potential safety and efficacy of its products in development, and commercialization and partnering strategy. The Company's actual results may differ materially from those indicated in these forward-looking statements based on a number of factors, including risks and uncertainties associated with th...

Genomic Health Announces Second Quarter 2009 Financial Results and Business Progress

...ity of clinical study results to actual outcomes. Forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially, and reported results should not be considered as an indication of future performance. These risks and uncertainties include, but are not l...

Micromet Closes $80.5 Million Public Offering of Common Stock

...pates," "intends," or the negative of those words or other similar words to be uncertain and forward-looking. Factors that may cause actual results to differ materially from any future results expressed or implied by any forward-looking statements include the risk that product candidates that appeared promi...
Other Tags
(Date:7/30/2014)... American Chemical Society (ACS) announced today that David L. ... ACS Biomaterials Science & Engineering as editor-in-chief. With ... the new journal will feature high-quality research in the ... or naturally derived materials that interact with living or ... it reflects the tremendous growth in the field of ...
(Date:7/30/2014)... the Entomological Society of America (ESA) has elected ten ... as a Fellow acknowledges outstanding contributions to entomology in ... or administration. The following Fellows will be recognized during ... will be held November 16-19, 2014 in Portland, Oregon. ... professor with the Department of Plant, Soil and Entomological ...
(Date:7/30/2014)... Press (OUP) is pleased to announce its new relationship ... 2015, OUP and CINP will partner to publish ... a fully open-access journal. , Alan Frazer, Editor-in-Chief of ... size and expertise of OUP will further facilitate the ... of the very leading journals within neuropsychopharmacology. The conversion ...
Breaking Biology News(10 mins):ACS Biomaterials Science & Engineering: Brand-new journal launches in 2015, names editor 2Entomological Society of America recognizes 2014 fellows 2Entomological Society of America recognizes 2014 fellows 3Entomological Society of America recognizes 2014 fellows 4Entomological Society of America recognizes 2014 fellows 5Entomological Society of America recognizes 2014 fellows 6Entomological Society of America recognizes 2014 fellows 7Entomological Society of America recognizes 2014 fellows 8Entomological Society of America recognizes 2014 fellows 9Entomological Society of America recognizes 2014 fellows 10Entomological Society of America recognizes 2014 fellows 11Entomological Society of America recognizes 2014 fellows 12Entomological Society of America recognizes 2014 fellows 13Entomological Society of America recognizes 2014 fellows 14Entomological Society of America recognizes 2014 fellows 15Entomological Society of America recognizes 2014 fellows 16Entomological Society of America recognizes 2014 fellows 17OUP to partner with the International College of Neuropsychopharmacology 2
(Date:7/31/2014)... 2014 Many lawyers take up the law ... correct injustices, and preserve the rule of law. Upholding these ... lauded as crusading and exemplary by some, but reckless and ... whose seed might be planted within the legal system itself, ... punishment for an attorney - a referral to the bar's ...
(Date:7/31/2014)... New York, NY (PRWEB) July 31, 2014 ... managed IT solutions firm based in New York City, ... cabling infrastructure for the midtown Manhattan headquarters of a ... in corporate and investment banking. , Chico Ramnarayan, Chief ... with our client is an opportunity for us to ...
(Date:7/31/2014)... Loffler Companies, the leading business technology and services ... as a Microsoft Community Connections Partner of the Year ... 2014. , The Microsoft U.S. SMB Champions Club ... IT services and solutions to small and midsized business ... Champions Club member, Loffler has established a proven track ...
(Date:7/31/2014)... According to new research report "Meat Substitutes Market ... Tofu-Based Product, Tempeh, TVP, Seitan, Quorn, Others), by ... to 2019", defines and segments the global Meat ... the market value of sources, types, and categories ... driving and restraining factors for the global market ...
(Date:7/31/2014)... Angeles, California (PRWEB) July 31, 2014 ... program all year round to CEO Belina Calderon’s ... employment services and medical billing, 1Heart Caregiver Services, ... 1Heart Business Academy applauds the most recent resource ... Commerce Ambassador Glenn Bowie for sharing his expertise ...
Breaking Medicine News(10 mins):Health News:Supreme Court Press Petition of the Month for July 2014: Shutting Down Inconvenient Lawyers By Disbarment or Suspension 2Health News:Supreme Court Press Petition of the Month for July 2014: Shutting Down Inconvenient Lawyers By Disbarment or Suspension 3Health News:Global Bank Awards CRA with Network Infrastructure Contract 2Health News:Loffler Companies Named Microsoft Community Connections Partner of the Year Award Winner 2Health News:Loffler Companies Named Microsoft Community Connections Partner of the Year Award Winner 3Health News:Meat Substitutes Market Worth $4,622.4 Million by 2019 - New Report by MarketsandMarkets 2Health News:Meat Substitutes Market Worth $4,622.4 Million by 2019 - New Report by MarketsandMarkets 3Health News:1Heart Business Academy Applauds Resource Speaker and Trainer Los Angeles Area Chamber of Commerce Ambassador Glenn Bowie 2Health News:1Heart Business Academy Applauds Resource Speaker and Trainer Los Angeles Area Chamber of Commerce Ambassador Glenn Bowie 3Health News:1Heart Business Academy Applauds Resource Speaker and Trainer Los Angeles Area Chamber of Commerce Ambassador Glenn Bowie 4
Other Contents